New triple therapy shows promise for hip bone death
NCT ID NCT07560163
First seen May 06, 2026 · Last updated May 19, 2026 · Updated 3 times
Summary
This study tested a combination of three treatments—core decompression, stromal vascular fraction (a type of cell therapy), and hyperbaric oxygen therapy—in 24 patients with early-stage osteonecrosis (bone death) of the hip. The goal was to improve hip function and stop the disease from getting worse. After two years, the researchers measured changes in hip scores and checked if any patients needed a hip replacement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEONECROSIS OF THE FEMORAL HEAD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ankara Bilkent City Hospital
Ankara, 06800, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.